Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Verrill, M
   Anthracyclines in breast cancer: therapy and issues of toxicity
   BREAST
   
   M. Verrill, "Anthracyclines in breast cancer: therapy and issues of toxicity", BREAST, 10, 2001, pp. 8-15
2. Dazzi, H; Kaufmann, K; Follath, F
   Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996
   ANNALS OF ONCOLOGY
   
   H. Dazzi et al., "Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996", ANN ONCOL, 12(7), 2001, pp. 963-966
3. Batist, G; Ramakrishnan, G; Rao, CS; Chandrasekharan, A; Gutheil, J; Guthrie, T; Shah, P; Khojasteh, A; Nair, MK; Hoelzer, K; Tkaczuk, K; Park, YC; Lee, LW
   Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   G. Batist et al., "Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer", J CL ONCOL, 19(5), 2001, pp. 1444-1454
4. Kremer, LCM; van Dalen, EC; Offringa, M; Ottenkamp, J; Voute, PA
   Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study
   JOURNAL OF CLINICAL ONCOLOGY
   
   L.C.M. Kremer et al., "Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study", J CL ONCOL, 19(1), 2001, pp. 191-196
5. Iarussi, D; Galderisi, M; Ratti, G; Tedesco, MA; Indolfi, P; Casale, F; Di Tullio, MT; de Divitiis, O; Iacono, A
   Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood
   CLINICAL CARDIOLOGY
   
   D. Iarussi et al., "Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood", CLIN CARD, 24(10), 2001, pp. 663-669
6. De Beer, EL; Bottone, AE; Voest, EE
   Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   E.L. De Beer et al., "Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review", EUR J PHARM, 415(1), 2001, pp. 1-11
7. Zhou, SY; Starkov, A; Froberg, MK; Leino, RL; Wallace, KB
   Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin
   CANCER RESEARCH
   
   S.Y. Zhou et al., "Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin", CANCER RES, 61(2), 2001, pp. 771-777
8. Horenstein, MS; Vander Heide, RS; L'Ecuyer, TJ
   Molecular basis of anthracycline-induced cardiotoxicity and its prevention
   MOLECULAR GENETICS AND METABOLISM
   
   M.S. Horenstein et al., "Molecular basis of anthracycline-induced cardiotoxicity and its prevention", MOL GEN MET, 71(1-2), 2000, pp. 436-444
9. Eidenschink, AB; Schroter, G; Muller-Weihrich, S; Stern, H
   Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood
   CARDIOLOGY IN THE YOUNG
   
   A.B. Eidenschink et al., "Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood", CARD YOUNG, 10(6), 2000, pp. 610-617
10. Birtle, AJ
    Anthracyclines and cardiotoxicity
    CLINICAL ONCOLOGY
    
    A.J. Birtle, "Anthracyclines and cardiotoxicity", CL ONCOL-UK, 12(3), 2000, pp. 146-152
11. Kishi, S; Yoshida, A; Yamauchi, T; Tsutani, H; Lee, JD; Nakamura, T; Naiki, H; Ueda, T
    Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemia
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    S. Kishi et al., "Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemia", INT J HEMAT, 71(2), 2000, pp. 172-179
12. Cardinale, D; Sandri, MT; Martinoni, A; Tricca, A; Civelli, M; Lamantia, G; Cinieri, S; Martinelli, G; Cipolla, CM; Fiorentini, C
    Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D. Cardinale et al., "Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy", J AM COL C, 36(2), 2000, pp. 517-522
13. Herman, EH; Zhang, J; Chadwick, DP; Ferrans, VJ
    Comparison of the protective effects of amifostine and dexrazoxane againstthe toxicity of doxorubicin in spontaneously hypertensive rats
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    E.H. Herman et al., "Comparison of the protective effects of amifostine and dexrazoxane againstthe toxicity of doxorubicin in spontaneously hypertensive rats", CANC CHEMOT, 45(4), 2000, pp. 329-334
14. Iarussi, D; Indolfi, P; Galderisi, M; Bossone, E
    Cardiac toxicity after anthracycline chemotherapy in childhood
    HERZ
    
    D. Iarussi et al., "Cardiac toxicity after anthracycline chemotherapy in childhood", HERZ, 25(7), 2000, pp. 676-688
15. Conklin, KA
    Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
    
    K.A. Conklin, "Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects", NUTR CANCER, 37(1), 2000, pp. 1-18
16. Cirillo, R; Sacco, G; Venturella, S; Brightwell, J; Giachetti, A; Manzini, S
    Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    R. Cirillo et al., "Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat", J CARDIO PH, 35(1), 2000, pp. 100-108
17. Weinstein, DM; Mihm, MJ; Bauer, JA
    Cardiac peroxynitrite formation and left ventricular dysfunction followingdoxorubicin treatment in mice
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    D.M. Weinstein et al., "Cardiac peroxynitrite formation and left ventricular dysfunction followingdoxorubicin treatment in mice", J PHARM EXP, 294(1), 2000, pp. 396-401
18. Fredericks, S; Collinson, PO; Holt, DW
    Response to "Increased creatine kinase MB and cardiac troponin T with normal cardiac troponin I in metastatic alveolar rhabdomyosarcoma"
    CLINICAL CHEMISTRY
    
    S. Fredericks et al., "Response to "Increased creatine kinase MB and cardiac troponin T with normal cardiac troponin I in metastatic alveolar rhabdomyosarcoma"", CLIN CHEM, 46(3), 2000, pp. 432-433
19. Pritsos, CA; Ma, J
    Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity
    CHEMICO-BIOLOGICAL INTERACTIONS
    
    C.A. Pritsos e J. Ma, "Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity", CHEM-BIO IN, 127(1), 2000, pp. 1-11
20. Forrest, GL; Gonzalez, B; Tseng, W; Li, XL; Mann, J
    Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice
    CANCER RESEARCH
    
    G.L. Forrest et al., "Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice", CANCER RES, 60(18), 2000, pp. 5158-5164
21. Kawabata, H; Ryomoto, T; Ishikawa, K
    Effect of beta-blocker on metabolism and contraction of doxorubicin-induced cardiotoxicity in the isolated perfused rabbit heart
    ANGIOLOGY
    
    H. Kawabata et al., "Effect of beta-blocker on metabolism and contraction of doxorubicin-induced cardiotoxicity in the isolated perfused rabbit heart", ANGIOLOGY, 51(5), 2000, pp. 405-413
22. Nousiainen, T; Vanninen, E; Rantala, A; Jantunen, E; Hartikainen, J
    QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma - Introduction
    JOURNAL OF INTERNAL MEDICINE
    
    T. Nousiainen et al., "QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma - Introduction", J INTERN M, 245(4), 1999, pp. 359-364
23. Chan, S; Friedrichs, K; Noel, D; Pinter, T; Van Belle, S; Vorobiof, D; Duarte, R; Gil, MG; Bodrogi, I; Murray, E; Yelle, L; von Minckwitz, G; Korec, S; Simmonds, P; Buzzi, F; Mancha, RG; Richardson, G; Walpole, E; Ronzoni, M; Murawsky, M; Alakl, M; Riva, A; Crown, J
    Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    S. Chan et al., "Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer", J CL ONCOL, 17(8), 1999, pp. 2341-2354
24. Herman, EH; Zhang, J; Lipshultz, SE; Rifai, N; Chadwick, D; Takeda, K; Yu, ZX; Ferrans, VJ
    Correlation between serum levels of cardiac troponin-T and the severity ofthe chronic cardiomyopathy induced by doxorubicin
    JOURNAL OF CLINICAL ONCOLOGY
    
    E.H. Herman et al., "Correlation between serum levels of cardiac troponin-T and the severity ofthe chronic cardiomyopathy induced by doxorubicin", J CL ONCOL, 17(7), 1999, pp. 2237-2243
25. Gennari, A; Salvadori, B; Donati, S; Bengala, C; Orlandini, C; Danesi, R; Del Tacca, M; Bruzzi, P; Conte, PF
    Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Gennari et al., "Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors", J CL ONCOL, 17(11), 1999, pp. 3596-3602
26. Crown, J
    Phase III randomized trials of docetaxel in patients with metastatic breast cancer
    SEMINARS IN ONCOLOGY
    
    J. Crown, "Phase III randomized trials of docetaxel in patients with metastatic breast cancer", SEMIN ONCOL, 26(3), 1999, pp. 33-38
27. Levitt, G
    Cardioprotection
    BRITISH JOURNAL OF HAEMATOLOGY
    
    G. Levitt, "Cardioprotection", BR J HAEM, 106(4), 1999, pp. 860-869
28. Suzuki, J; Yanagisawa, A; Shigeyama, T; Tsubota, J; Yasumura, T; Shimoyama, K; Ishikawa, K
    Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography
    ANGIOLOGY
    
    J. Suzuki et al., "Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography", ANGIOLOGY, 50(1), 1999, pp. 37-45
29. BOTTONE AE; VOEST EE; DEBEER EL
    IMPAIRMENT OF THE ACTIN-MYOSIN INTERACTION IN PERMEABILIZED CARDIAC TRABECULAE AFTER CHRONIC DOXORUBICIN TREATMENT
    Clinical cancer research
    
    A.E. Bottone et al., "IMPAIRMENT OF THE ACTIN-MYOSIN INTERACTION IN PERMEABILIZED CARDIAC TRABECULAE AFTER CHRONIC DOXORUBICIN TREATMENT", Clinical cancer research, 4(4), 1998, pp. 1031-1037
30. BOTTONE AE; VOEST EE; DEBEER EL
    IMPAIRMENT OF THE ACTIN-MYOSIN INTERACTION IN PERMEABILIZED CARDIAC TRABECULAE AFTER CHRONIC DOXORUBICIN TREATMENT
    Clinical cancer research
    
    A.E. Bottone et al., "IMPAIRMENT OF THE ACTIN-MYOSIN INTERACTION IN PERMEABILIZED CARDIAC TRABECULAE AFTER CHRONIC DOXORUBICIN TREATMENT", Clinical cancer research, 4(4), 1998, pp. 1031-1037
31. NOHL H; GILLE L; STANIEK K
    THE EXOGENOUS NADH DEHYDROGENASE OF HEART-MITOCHONDRIA IS THE KEY ENZYME RESPONSIBLE FOR SELECTIVE CARDIOTOXICITY OF ANTHRACYCLINES
    Zeitschrift fur Naturforschung. C, A journal of biosciences
    
    H. Nohl et al., "THE EXOGENOUS NADH DEHYDROGENASE OF HEART-MITOCHONDRIA IS THE KEY ENZYME RESPONSIBLE FOR SELECTIVE CARDIOTOXICITY OF ANTHRACYCLINES", Zeitschrift fur Naturforschung. C, A journal of biosciences, 53(3-4), 1998, pp. 279-285
32. ALSHABANAH OA; BADARY OA; NAGI MN; ALGHARABLY NM; ALRIKABI AC; ALBEKAIRI AM
    THYMOQUINONE PROTECTS AGAINST DOXORUBICIN-INDUCED CARDIOTOXICITY WITHOUT COMPROMISING ITS ANTITUMOR-ACTIVITY
    Journal of experimental & clinical cancer research
    
    O.A. Alshabanah et al., "THYMOQUINONE PROTECTS AGAINST DOXORUBICIN-INDUCED CARDIOTOXICITY WITHOUT COMPROMISING ITS ANTITUMOR-ACTIVITY", Journal of experimental & clinical cancer research, 17(2), 1998, pp. 193-198
33. COTTIN Y; TOUZERY C; DALLOZ F; COUDERT B; TOUBEAU M; RIEDINGER A; LOUIS P; WOLF JE; BRUNOTTE F
    COMPARISON OF EPIRUBICIN AND DOXORUBICIN CARDIOTOXICITY INDUCED BY LOW-DOSES - EVOLUTION OF THE DIASTOLIC AND SYSTOLIC PARAMETERS STUDIED BY RADIONUCLIDE ANGIOGRAPHY
    Clinical cardiology
    
    Y. Cottin et al., "COMPARISON OF EPIRUBICIN AND DOXORUBICIN CARDIOTOXICITY INDUCED BY LOW-DOSES - EVOLUTION OF THE DIASTOLIC AND SYSTOLIC PARAMETERS STUDIED BY RADIONUCLIDE ANGIOGRAPHY", Clinical cardiology, 21(9), 1998, pp. 665-670
34. MYERS C
    THE ROLE OF IRON IN DOXORUBICIN-INDUCED CARDIOMYOPATHY
    Seminars in oncology
    
    C. Myers, "THE ROLE OF IRON IN DOXORUBICIN-INDUCED CARDIOMYOPATHY", Seminars in oncology, 25(4), 1998, pp. 10-14
35. HERMAN EH; FERRANS V
    PRECLINICAL ANIMAL-MODELS OF CARDIAC PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY
    Seminars in oncology
    
    E.H. Herman e V. Ferrans, "PRECLINICAL ANIMAL-MODELS OF CARDIAC PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY", Seminars in oncology, 25(4), 1998, pp. 15-21
36. IMONDI AR
    PRECLINICAL MODELS OF CARDIAC PROTECTION AND TESTING FOR EFFECTS OF DEXRAZOXANE ON DOXORUBICIN ANTITUMOR EFFECTS
    Seminars in oncology
    
    A.R. Imondi, "PRECLINICAL MODELS OF CARDIAC PROTECTION AND TESTING FOR EFFECTS OF DEXRAZOXANE ON DOXORUBICIN ANTITUMOR EFFECTS", Seminars in oncology, 25(4), 1998, pp. 22-30
37. SINGAL PK; ILISKOVIC N
    DOXORUBICIN-INDUCED CARDIOMYOPATHY
    The New England journal of medicine
    
    P.K. Singal e N. Iliskovic, "DOXORUBICIN-INDUCED CARDIOMYOPATHY", The New England journal of medicine, 339(13), 1998, pp. 900-905
38. WISEMAN LR; SPENCER CM
    DEXRAZOXANE - A REVIEW OF ITS USE AS A CARDIOPROTECTIVE AGENT IN PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
    Drugs
    
    L.R. Wiseman e C.M. Spencer, "DEXRAZOXANE - A REVIEW OF ITS USE AS A CARDIOPROTECTIVE AGENT IN PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY", Drugs, 56(3), 1998, pp. 385-403
39. SCHWARZ ER; POLLICK C; DOW J; PATTERSON M; BIRNBAUM Y; KLONER RA
    A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY
    Cardiovascular Research
    
    E.R. Schwarz et al., "A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY", Cardiovascular Research, 39(1), 1998, pp. 216-223
40. VENDITTI P; BALESTRIERI M; DELEO T; DIMEO S
    FREE-RADICAL INVOLVEMENT IN DOXORUBICIN-INDUCED ELECTROPHYSIOLOGICAL ALTERATIONS IN RAT PAPILLARY-MUSCLE FIBERS
    Cardiovascular Research
    
    P. Venditti et al., "FREE-RADICAL INVOLVEMENT IN DOXORUBICIN-INDUCED ELECTROPHYSIOLOGICAL ALTERATIONS IN RAT PAPILLARY-MUSCLE FIBERS", Cardiovascular Research, 38(3), 1998, pp. 695-702
41. SCHAADT B; KELBAEK H
    AGE AND LEFT-VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ADVANCED BREAST-CANCER AT HIGH-RISK FOR DEVELOPMENT OF EPIRUBICIN-INDUCEDHEART-FAILURE
    Journal of nuclear cardiology
    
    B. Schaadt e H. Kelbaek, "AGE AND LEFT-VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ADVANCED BREAST-CANCER AT HIGH-RISK FOR DEVELOPMENT OF EPIRUBICIN-INDUCEDHEART-FAILURE", Journal of nuclear cardiology, 4(6), 1997, pp. 494-501
42. HERMAN EH; FERRANS VJ
    ANIMAL-MODELS OF ANTHRACYCLINE CARDIOTOXICITY - BASIC MECHANISMS AND CARDIOPROTECTIVE ACTIVITY
    Progress in pediatric cardiology
    
    E.H. Herman e V.J. Ferrans, "ANIMAL-MODELS OF ANTHRACYCLINE CARDIOTOXICITY - BASIC MECHANISMS AND CARDIOPROTECTIVE ACTIVITY", Progress in pediatric cardiology, 8(2), 1997, pp. 49-58
43. BOUCEK RJ
    MECHANISMS FOR ANTHRACYCLINE-INDUCED CARDIOMYOPATHY - CLINICAL AND LABORATORY CORRELATIONS
    Progress in pediatric cardiology
    
    R.J. Boucek, "MECHANISMS FOR ANTHRACYCLINE-INDUCED CARDIOMYOPATHY - CLINICAL AND LABORATORY CORRELATIONS", Progress in pediatric cardiology, 8(2), 1997, pp. 59-70
44. PROPPER D; MASER E
    CARBONYL REDUCTION OF DAUNORUBICIN IN RABBIT LIVER AND HEART
    Pharmacology & toxicology
    
    D. Propper e E. Maser, "CARBONYL REDUCTION OF DAUNORUBICIN IN RABBIT LIVER AND HEART", Pharmacology & toxicology, 80(5), 1997, pp. 240-245
45. WEIJL NI; CLETON FJ; OSANTO S
    FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY
    Cancer treatment reviews
    
    N.I. Weijl et al., "FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY", Cancer treatment reviews, 23(4), 1997, pp. 209-240
46. MAEDA A; HONDA M; KURAMOCHI T; TANAKA K; TAKABATAKE T
    AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR PROTECTS AGAINST DOXORUBICIN-INDUCED IMPAIRMENT OF CALCIUM HANDLING IN NEONATAL RAT CARDIAC MYOCYTES
    Clinical and experimental pharmacology and physiology
    
    A. Maeda et al., "AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR PROTECTS AGAINST DOXORUBICIN-INDUCED IMPAIRMENT OF CALCIUM HANDLING IN NEONATAL RAT CARDIAC MYOCYTES", Clinical and experimental pharmacology and physiology, 24(9-10), 1997, pp. 720-726
47. DREICER R; KARWAL MW; MIDENCE G; DAVIS CS; NETTLEMAN M
    THE ROLE OF RADIONUCLIDE ANGIOCARDIOGRAPHY IN THE TREATMENT OF PATIENTS RECEIVING DOXORUBICIN-BASED CHEMOTHERAPY - A REASSESSMENT
    American journal of clinical oncology
    
    R. Dreicer et al., "THE ROLE OF RADIONUCLIDE ANGIOCARDIOGRAPHY IN THE TREATMENT OF PATIENTS RECEIVING DOXORUBICIN-BASED CHEMOTHERAPY - A REASSESSMENT", American journal of clinical oncology, 20(2), 1997, pp. 132-137
48. KAKADEKAR AP; SANDOR GGS; FRYER C; CHAN KW; ROGERS PC; PRITCHARD S; POPOV R
    DIFFERENCES IN DOSE SCHEDULING AS A FACTOR IN THE ETIOLOGY OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN EWING SARCOMA PATIENTS
    Medical and pediatric oncology
    
    A.P. Kakadekar et al., "DIFFERENCES IN DOSE SCHEDULING AS A FACTOR IN THE ETIOLOGY OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN EWING SARCOMA PATIENTS", Medical and pediatric oncology, 28(1), 1997, pp. 22-26
49. PALMEIRA CM; SERRANO J; KUEHL DW; WALLACE KB
    PREFERENTIAL OXIDATION OF CARDIAC MITOCHONDRIAL-DNA FOLLOWING ACUTE INTOXICATION WITH DOXORUBICIN
    Biochimica et biophysica acta. Bioenergetics
    
    C.M. Palmeira et al., "PREFERENTIAL OXIDATION OF CARDIAC MITOCHONDRIAL-DNA FOLLOWING ACUTE INTOXICATION WITH DOXORUBICIN", Biochimica et biophysica acta. Bioenergetics, 1321(2), 1997, pp. 101-106
50. LEISCHIK R; EISING EG; KATZ M; GLATTKI G; BRUCH C; SEEBER S; BOCKISCH A; ERBEL R
    STRESS ECHOCARDIOGRAPHY COMPARED WITH RAD IONUCLIDE VENTRICULOGRAPHY IN THE DIAGNOSIS OF CARDIOMYOPATHY IN PATIENTS RECEIVING CHEMOTHERAPY FOR MALIGNANT-TUMOR
    Deutsche Medizinische Wochenschrift
    
    R. Leischik et al., "STRESS ECHOCARDIOGRAPHY COMPARED WITH RAD IONUCLIDE VENTRICULOGRAPHY IN THE DIAGNOSIS OF CARDIOMYOPATHY IN PATIENTS RECEIVING CHEMOTHERAPY FOR MALIGNANT-TUMOR", Deutsche Medizinische Wochenschrift, 122(49), 1997, pp. 1509-1515
51. FERRARI S; FIGUS E; CAGNANO R; IANTORNO D; BACCI G
    THE ROLE OF CORRECTED QT INTERVAL IN THE CARDIOLOGIC FOLLOW-UP OF YOUNG-PATIENTS TREATED WITH ADRIAMYCIN
    Journal of chemotherapy
    
    S. Ferrari et al., "THE ROLE OF CORRECTED QT INTERVAL IN THE CARDIOLOGIC FOLLOW-UP OF YOUNG-PATIENTS TREATED WITH ADRIAMYCIN", Journal of chemotherapy, 8(3), 1996, pp. 232-236
52. PIHKALA J
    ANTHRACYCLINE CARDIOMYOPATHY AND IMPAIRED MYOCARDIAL-FUNCTION IN CHILDREN - OUTCOME WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR AND DIGOXIN THERAPY
    International journal of pediatric hematology/oncology
    
    J. Pihkala, "ANTHRACYCLINE CARDIOMYOPATHY AND IMPAIRED MYOCARDIAL-FUNCTION IN CHILDREN - OUTCOME WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR AND DIGOXIN THERAPY", International journal of pediatric hematology/oncology, 3(3), 1996, pp. 163-170
53. COTTIN Y; TOUZERY C; COUDERT B; RICHEBOURG S; COHEN M; TOUBEAU M; LOUIS P; WOLF JE; BRUNOTTE F
    DIASTOLIC OR SYSTOLIC LEFT AND RIGHT-VENTRICULAR IMPAIRMENT AT MODERATE DOSES OF ANTHRACYCLINE - A 1-YEAR FOLLOW-UP-STUDY OF WOMEN
    European journal of nuclear medicine
    
    Y. Cottin et al., "DIASTOLIC OR SYSTOLIC LEFT AND RIGHT-VENTRICULAR IMPAIRMENT AT MODERATE DOSES OF ANTHRACYCLINE - A 1-YEAR FOLLOW-UP-STUDY OF WOMEN", European journal of nuclear medicine, 23(5), 1996, pp. 511-516
54. ROMEROALVIRA D; ROCHE E; PLACER L
    CARDIOMYOPATHIES AND OXIDATIVE STRESS
    Medical hypotheses
    
    D. Romeroalvira et al., "CARDIOMYOPATHIES AND OXIDATIVE STRESS", Medical hypotheses, 47(2), 1996, pp. 137-144
55. HOYANO Y; FURUKAWA Y; OGUCHI T; KASAMA M; IMAMURA H; CHIBA S
    ACUTE PRESYNAPTIC INHIBITION BY DOXORUBICIN OF NEGATIVE CHRONOTROPIC AND INOTROPIC RESPONSES TO PARASYMPATHETIC NERVE-STIMULATION IN ISOLATED, BLOOD-PERFUSED DOG ATRIUM
    Journal of cardiovascular pharmacology
    
    Y. Hoyano et al., "ACUTE PRESYNAPTIC INHIBITION BY DOXORUBICIN OF NEGATIVE CHRONOTROPIC AND INOTROPIC RESPONSES TO PARASYMPATHETIC NERVE-STIMULATION IN ISOLATED, BLOOD-PERFUSED DOG ATRIUM", Journal of cardiovascular pharmacology, 27(1), 1996, pp. 37-41
56. DORR RT
    CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES
    Seminars in oncology
    
    R.T. Dorr, "CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES", Seminars in oncology, 23(4), 1996, pp. 23-34
57. DEWOLF D; SUYS B; MAURUS R; BENOIT Y; VERHAAREN H; MATTHIJS D; OTTEN J
    DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE EVALUATION OF LATE ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOOD-CANCER SURVIVORS
    Pediatric research
    
    D. Dewolf et al., "DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE EVALUATION OF LATE ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOOD-CANCER SURVIVORS", Pediatric research, 39(3), 1996, pp. 504-512
58. GANZ WI; SRIDHAR KS; GANZ SS; GONZALEZ R; CHAKKO S; SERAFINI A
    REVIEW OF TESTS FOR MONITORING DOXORUBICIN-INDUCED CARDIOMYOPATHY
    Oncology
    
    W.I. Ganz et al., "REVIEW OF TESTS FOR MONITORING DOXORUBICIN-INDUCED CARDIOMYOPATHY", Oncology, 53(6), 1996, pp. 461-470
59. SOLEM LE; HELLER LJ; WALLACE KB
    DOSE-DEPENDENT INCREASE IN SENSITIVITY TO CALCIUM-INDUCED MITOCHONDRIAL DYSFUNCTION AND CARDIOMYOCYTE CELL INJURY BY DOXORUBICIN
    Journal of Molecular and Cellular Cardiology
    
    L.E. Solem et al., "DOSE-DEPENDENT INCREASE IN SENSITIVITY TO CALCIUM-INDUCED MITOCHONDRIAL DYSFUNCTION AND CARDIOMYOCYTE CELL INJURY BY DOXORUBICIN", Journal of Molecular and Cellular Cardiology, 28(5), 1996, pp. 1023-1032
60. ANDREANI A; RAMBALDI M; LEONI A; LOCATELLI A; BOSSA R; FRACCARI A; GALATULAS I; SALVATORE G
    POTENTIAL ANTITUMOR AGENTS .24. SYNTHESIS AND PHARMACOLOGICAL BEHAVIOR OF IMIDAZO[2,1-B]THIAZOLE GUANYLHYDRAZONES BEARING AT LEAST ONE CHLORINE
    Journal of medicinal chemistry
    
    A. Andreani et al., "POTENTIAL ANTITUMOR AGENTS .24. SYNTHESIS AND PHARMACOLOGICAL BEHAVIOR OF IMIDAZO[2,1-B]THIAZOLE GUANYLHYDRAZONES BEARING AT LEAST ONE CHLORINE", Journal of medicinal chemistry, 39(14), 1996, pp. 2852-2855
61. KOJIMA S
    NEOPTERIN AS AN ENDOGENOUS ANTIOXIDANT
    Eisei Kagaku
    
    S. Kojima, "NEOPTERIN AS AN ENDOGENOUS ANTIOXIDANT", Eisei Kagaku, 42(4), 1996, pp. 273-284
62. CHAN EM; THOMAS MJ; BANDY B; TIBBITS GF
    EFFECTS OF DOXORUBICIN, 4'-EPIRUBICIN, AND ANTIOXIDANT ENZYMES ON THECONTRACTILITY OF ISOLATED CARDIOMYOCYTES
    Canadian journal of physiology and pharmacology
    
    E.M. Chan et al., "EFFECTS OF DOXORUBICIN, 4'-EPIRUBICIN, AND ANTIOXIDANT ENZYMES ON THECONTRACTILITY OF ISOLATED CARDIOMYOCYTES", Canadian journal of physiology and pharmacology, 74(8), 1996, pp. 904-910
63. BULOCK FA; MOTT MG; OAKHILL A; MARTIN RP
    EARLY IDENTIFICATION OF ANTHRACYCLINE CARDIOMYOPATHY - POSSIBILITIES AND IMPLICATIONS
    Archives of Disease in Childhood
    
    F.A. Bulock et al., "EARLY IDENTIFICATION OF ANTHRACYCLINE CARDIOMYOPATHY - POSSIBILITIES AND IMPLICATIONS", Archives of Disease in Childhood, 75(5), 1996, pp. 416-422
64. SHAN K; LINCOFF AM; YOUNG JB
    ANTHRACYCLINE-INDUCED CARDIOTOXICITY
    Annals of internal medicine
    
    K. Shan et al., "ANTHRACYCLINE-INDUCED CARDIOTOXICITY", Annals of internal medicine, 125(1), 1996, pp. 47-58
65. PIERGIES AA; BENSON AB
    PHARMACOKINETICS AND ACUTE CARDIOVASCULAR EFFECTS OF MENOGARIL IN PATIENTS WITH METASTATIC TUMORS
    International journal of clinical pharmacology and therapeutics
    
    A.A. Piergies e A.B. Benson, "PHARMACOKINETICS AND ACUTE CARDIOVASCULAR EFFECTS OF MENOGARIL IN PATIENTS WITH METASTATIC TUMORS", International journal of clinical pharmacology and therapeutics, 33(2), 1995, pp. 63-69
66. LLESUY S; MILEI J; PICONE V; FLECHA BG; BEIGELMAN R; BOVERIS A
    EFFECT OF VITAMIN-A AND VITAMIN-E ON ISCHEMIA-REPERFUSION DAMAGE IN RABBIT HEART
    Molecular and cellular biochemistry
    
    S. Llesuy et al., "EFFECT OF VITAMIN-A AND VITAMIN-E ON ISCHEMIA-REPERFUSION DAMAGE IN RABBIT HEART", Molecular and cellular biochemistry, 145(1), 1995, pp. 45-51
67. FINK FM; GENSER N; FINK C; FALK M; MAIR J; MAURERDENGG K; HAMMERER I; PUSCHENDORF B
    CARDIAC TROPONIN-T AND CREATINE-KINASE MB MASS CONCENTRATIONS IN CHILDREN RECEIVING ANTHRACYCLINE CHEMOTHERAPY
    Medical and pediatric oncology
    
    F.M. Fink et al., "CARDIAC TROPONIN-T AND CREATINE-KINASE MB MASS CONCENTRATIONS IN CHILDREN RECEIVING ANTHRACYCLINE CHEMOTHERAPY", Medical and pediatric oncology, 25(3), 1995, pp. 185-189
68. STEINHERZ LJ; STEINHERZ PG; TAN C
    CARDIAC-FAILURE AND DYSRHYTHMIAS 6-19 YEARS AFTER ANTHRACYCLINE THERAPY - A SERIES OF 15 PATIENTS
    Medical and pediatric oncology
    
    L.J. Steinherz et al., "CARDIAC-FAILURE AND DYSRHYTHMIAS 6-19 YEARS AFTER ANTHRACYCLINE THERAPY - A SERIES OF 15 PATIENTS", Medical and pediatric oncology, 24(6), 1995, pp. 352-361
69. YAMASHITA J; OGAWA M; SHIRAKUSA T
    PLASMA ENDOTHELIN-1 AS A MARKER FOR DOXORUBICIN CARDIOTOXICITY
    International journal of cancer
    
    J. Yamashita et al., "PLASMA ENDOTHELIN-1 AS A MARKER FOR DOXORUBICIN CARDIOTOXICITY", International journal of cancer, 62(5), 1995, pp. 542-547
70. COTTIN Y; TOUZERY C; COUDERT B; GILLES A; WALKER P; MASSING JL; TOUBEAU M; RIEDINGERBERRIOLO A; CAILLOT D; LOUIS P; WOLF JE; BRUNOTTE F
    IMPAIRMENT OF DIASTOLIC FUNCTION DURING SHORT-TERM ANTHRACYCLINE CHEMOTHERAPY
    British Heart Journal
    
    Y. Cottin et al., "IMPAIRMENT OF DIASTOLIC FUNCTION DURING SHORT-TERM ANTHRACYCLINE CHEMOTHERAPY", British Heart Journal, 73(1), 1995, pp. 61-64
71. SEIFERT CF; NESSER ME; THOMPSON DF
    DEXRAZOXANE IN THE PREVENTION OF DOXORUBICIN-INDUCED CARDIOTOXICITY
    The Annals of pharmacotherapy
    
    C.F. Seifert et al., "DEXRAZOXANE IN THE PREVENTION OF DOXORUBICIN-INDUCED CARDIOTOXICITY", The Annals of pharmacotherapy, 28(9), 1994, pp. 1063-1072
72. VALAGUSSA P; ZAMBETTI M; BIASI S; MOLITERNI A; ZUCALI R; BONADONNA G
    CARDIAC EFFECTS FOLLOWING ADJUVANT CHEMOTHERAPY AND BREAST IRRADIATION IN OPERABLE BREAST-CANCER
    Annals of oncology
    
    P. Valagussa et al., "CARDIAC EFFECTS FOLLOWING ADJUVANT CHEMOTHERAPY AND BREAST IRRADIATION IN OPERABLE BREAST-CANCER", Annals of oncology, 5(3), 1994, pp. 209-216
73. ROSSI F; FILIPPELLI W; RUSSO S; FILIPPELLI A; BERRINO L
    CARDIOTOXICITY OF DOXORUBICIN - EFFECTS OF DRUGS INHIBITING THE RELEASE OF VASOACTIVE SUBSTANCES
    Pharmacology & toxicology
    
    F. Rossi et al., "CARDIOTOXICITY OF DOXORUBICIN - EFFECTS OF DRUGS INHIBITING THE RELEASE OF VASOACTIVE SUBSTANCES", Pharmacology & toxicology, 75(2), 1994, pp. 99-107
74. HIRANO S; WAKAZONO K; AGATA N; IGUCHI H; TONE H
    COMPARISON OF CARDIOTOXICITY OF PIRARUBICIN, EPIRUBICIN AND DOXORUBICIN IN THE RAT
    Drugs under experimental and clinical research
    
    S. Hirano et al., "COMPARISON OF CARDIOTOXICITY OF PIRARUBICIN, EPIRUBICIN AND DOXORUBICIN IN THE RAT", Drugs under experimental and clinical research, 20(4), 1994, pp. 153-160
75. HERMAN EH; ZHANG J; FERRANS VJ
    COMPARISON OF THE PROTECTIVE EFFECTS OF DESFERRIOXAMINE AND ICRF-187 AGAINST DOXORUBICIN-INDUCED TOXICITY IN SPONTANEOUSLY HYPERTENSIVE RATS
    Cancer chemotherapy and pharmacology
    
    E.H. Herman et al., "COMPARISON OF THE PROTECTIVE EFFECTS OF DESFERRIOXAMINE AND ICRF-187 AGAINST DOXORUBICIN-INDUCED TOXICITY IN SPONTANEOUSLY HYPERTENSIVE RATS", Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 93-100
76. ADAM Z; ELBL L; VORLICEK J; HAJEK R; HAJEK D; HEJLOVA N; KRALOVA E; NOVOTNA H
    TREATMENT OF REFRACTORY MULTIPLE-MYELOMA WITH VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, AND WITH REPEATED APPLICATION OF CYCLOPHOSPHAMIDE (C-VAD)
    Acta medica austriaca
    
    Z. Adam et al., "TREATMENT OF REFRACTORY MULTIPLE-MYELOMA WITH VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, AND WITH REPEATED APPLICATION OF CYCLOPHOSPHAMIDE (C-VAD)", Acta medica austriaca, 21(4), 1994, pp. 111-115
77. KOJIMA S; IIZUKA H; YAMAGUCHI H; TANUMA S; KOCHI M; UENO Y
    ANTIOXIDATIVE ACTIVITY OF BENZYLIDENEASCORBATE AND ITS EFFECT ON ADRIAMYCIN-INDUCED CARDIOTOXICITY
    Anticancer research
    
    S. Kojima et al., "ANTIOXIDATIVE ACTIVITY OF BENZYLIDENEASCORBATE AND ITS EFFECT ON ADRIAMYCIN-INDUCED CARDIOTOXICITY", Anticancer research, 14(5A), 1994, pp. 1875-1880
78. OYAMADA H; YAMADA Y; NOMURA E; NAKANISHI Y; ABE S; HORIKOSHI N; OGIHARA A; AIBA K; INAMOTO Y
    RELIABILITY OF DATA OBTAINED BY RADIONUCLIDE ANGIOCARDIOGRAPHY IN FOLLOW-UP-STUDIES WITH SPECIAL REFERENCE TO INTRAOBSERVER AND INTEROBSERVER VARIATIONS
    Nuclear medicine communications
    
    H. Oyamada et al., "RELIABILITY OF DATA OBTAINED BY RADIONUCLIDE ANGIOCARDIOGRAPHY IN FOLLOW-UP-STUDIES WITH SPECIAL REFERENCE TO INTRAOBSERVER AND INTEROBSERVER VARIATIONS", Nuclear medicine communications, 15(9), 1994, pp. 690-696
79. SOLEM LE; HENRY TR; WALLACE KB
    DISRUPTION OF MITOCHONDRIAL CALCIUM HOMEOSTASIS FOLLOWING CHRONIC DOXORUBICIN ADMINISTRATION
    Toxicology and applied pharmacology
    
    L.E. Solem et al., "DISRUPTION OF MITOCHONDRIAL CALCIUM HOMEOSTASIS FOLLOWING CHRONIC DOXORUBICIN ADMINISTRATION", Toxicology and applied pharmacology, 129(2), 1994, pp. 214-222
80. ALI MK; EWER MS; GIBBS HR; SWAFFORD J; GRAFF KL
    LATE DOXORUBICIN-ASSOCIATED CARDIOTOXICITY IN CHILDREN - THE POSSIBLEROLE OF INTERCURRENT VIRAL-INFECTION
    Cancer
    
    M.K. Ali et al., "LATE DOXORUBICIN-ASSOCIATED CARDIOTOXICITY IN CHILDREN - THE POSSIBLEROLE OF INTERCURRENT VIRAL-INFECTION", Cancer, 74(1), 1994, pp. 182-188
81. JIANG JH; TEMMA K; AKERA T
    DOXORUBICIN-INDUCED CHANGES IN INTRACELLULAR CA2-PIG HEART( TRANSIENTS OBSERVED IN CARDIAC MYOCYTES ISOLATED FROM GUINEA)
    Canadian journal of physiology and pharmacology
    
    J.H. Jiang et al., "DOXORUBICIN-INDUCED CHANGES IN INTRACELLULAR CA2-PIG HEART( TRANSIENTS OBSERVED IN CARDIAC MYOCYTES ISOLATED FROM GUINEA)", Canadian journal of physiology and pharmacology, 72(6), 1994, pp. 622-631
82. COTTIN Y; RIBUOT C; MAUPOIL V; GODIN D; ARNOULD L; BRUNOTTE F; ROCHETTE L
    EARLY INCIDENCE OF ADRIAMYCIN TREATMENT ON CARDIAC PARAMETERS IN THE RAT
    Canadian journal of physiology and pharmacology
    
    Y. Cottin et al., "EARLY INCIDENCE OF ADRIAMYCIN TREATMENT ON CARDIAC PARAMETERS IN THE RAT", Canadian journal of physiology and pharmacology, 72(2), 1994, pp. 140-145
83. BAUER G; OCONNELL S; DEVEREUX D; MARTIN A
    REVERSAL OF DOXORUBICIN-IMPAIRED WOUND-HEALING USING TRIAD COMPOUND
    The American surgeon
    
    G. Bauer et al., "REVERSAL OF DOXORUBICIN-IMPAIRED WOUND-HEALING USING TRIAD COMPOUND", The American surgeon, 60(6), 1994, pp. 455-459
84. BAUER G; OCONNELL S; DEVEREUX D
    REVERSAL OF DOXORUBICIN-IMPAIRED WOUND-HEALING USING TRIAD COMPOUND
    The American surgeon
    
    G. Bauer et al., "REVERSAL OF DOXORUBICIN-IMPAIRED WOUND-HEALING USING TRIAD COMPOUND", The American surgeon, 60(3), 1994, pp. 175-179
85. GUSTAFSON DL; SWANSON JD; PRITSOS CA
    MODULATION OF GLUTATHIONE AND GLUTATHIONE-DEPENDENT ANTIOXIDANT ENZYMES IN MOUSE HEART FOLLOWING DOXORUBICIN THERAPY
    Free radical research communications
    
    D.L. Gustafson et al., "MODULATION OF GLUTATHIONE AND GLUTATHIONE-DEPENDENT ANTIOXIDANT ENZYMES IN MOUSE HEART FOLLOWING DOXORUBICIN THERAPY", Free radical research communications, 19(2), 1993, pp. 111-120
86. FERRARI E; TAILLAN B; DUJARDIN P; MORAND P
    CARDIOTOXICITY OF ANTHRACYCLINES - CLINICAL-FEATURES, INCIDENCE, MONITORING
    La Presse medicale
    
    E. Ferrari et al., "CARDIOTOXICITY OF ANTHRACYCLINES - CLINICAL-FEATURES, INCIDENCE, MONITORING", La Presse medicale, 22(21), 1993, pp. 999-1004
87. SCHWARTZ CL; HOBBIE WL; TRUESDELL S; CONSTINE LC; CLARK EB
    CORRECTED QT INTERVAL PROLONGATION IN ANTHRACYCLINE-TREATED SURVIVORSOF CHILDHOOD-CANCER
    Journal of clinical oncology
    
    C.L. Schwartz et al., "CORRECTED QT INTERVAL PROLONGATION IN ANTHRACYCLINE-TREATED SURVIVORSOF CHILDHOOD-CANCER", Journal of clinical oncology, 11(10), 1993, pp. 1906-1910
88. HERMAN EH; FERRANS VJ
    TIMING OF TREATMENT WITH ICRF-187 AND ITS EFFECT ON CHRONIC DOXORUBICIN CARDIOTOXICITY
    Cancer chemotherapy and pharmacology
    
    E.H. Herman e V.J. Ferrans, "TIMING OF TREATMENT WITH ICRF-187 AND ITS EFFECT ON CHRONIC DOXORUBICIN CARDIOTOXICITY", Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 445-449
89. LAUNCHBURY AP; HABBOUBI N
    EPIRUBICIN AND DOXORUBICIN - A COMPARISON OF THEIR CHARACTERISTICS, THERAPEUTIC ACTIVITY AND TOXICITY
    Cancer treatment reviews
    
    A.P. Launchbury e N. Habboubi, "EPIRUBICIN AND DOXORUBICIN - A COMPARISON OF THEIR CHARACTERISTICS, THERAPEUTIC ACTIVITY AND TOXICITY", Cancer treatment reviews, 19(3), 1993, pp. 197-228
90. MCLOON LK; LUO XX; WIRTSCHAFTER J
    ACUTE MORPHOLOGIC CHANGES IN ORBICULARIS OCULI MUSCLE AFTER DOXORUBICIN INJECTION INTO THE EYELID
    Muscle & nerve
    
    L.K. Mcloon et al., "ACUTE MORPHOLOGIC CHANGES IN ORBICULARIS OCULI MUSCLE AFTER DOXORUBICIN INJECTION INTO THE EYELID", Muscle & nerve, 16(7), 1993, pp. 737-743
91. EMBREE L; GELMON KA; LOHR A; MAYER LD; COLDMAN AJ; CULLIS PR; PALAITIS W; PILKIEWICZ F; HUDON NJ; HEGGIE JR; GOLDIE JH
    CHROMATOGRAPHIC ANALYSIS AND PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED DOXORUBICIN IN NON-SMALL-CELL LUNG-CANCER PATIENTS
    Journal of pharmaceutical sciences
    
    L. Embree et al., "CHROMATOGRAPHIC ANALYSIS AND PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED DOXORUBICIN IN NON-SMALL-CELL LUNG-CANCER PATIENTS", Journal of pharmaceutical sciences, 82(6), 1993, pp. 627-634
92. DODD DA; ATKINSON JB; OLSON RD; BUCK S; CUSACK BJ; FLEISCHER S; BOUCEK RJ
    DOXORUBICIN CARDIOMYOPATHY IS ASSOCIATED WITH A DECREASE IN CALCIUM RELEASE CHANNEL OF THE SARCOPLASMIC-RETICULUM IN A CHRONIC RABBIT MODEL
    The Journal of clinical investigation
    
    D.A. Dodd et al., "DOXORUBICIN CARDIOMYOPATHY IS ASSOCIATED WITH A DECREASE IN CALCIUM RELEASE CHANNEL OF THE SARCOPLASMIC-RETICULUM IN A CHRONIC RABBIT MODEL", The Journal of clinical investigation, 91(4), 1993, pp. 1697-1705
93. COWENS JW; CREAVEN PJ; GRECO WR; BRENNER DE; TUNG Y; OSTRO M; PILKIEWICZ F; GINSBERG R; PETRELLI N
    INITIAL CLINICAL (PHASE-I) TRIAL OF TLC D-99 (DOXORUBICIN ENCAPSULATED IN LIPOSOMES)
    Cancer research
    
    J.W. Cowens et al., "INITIAL CLINICAL (PHASE-I) TRIAL OF TLC D-99 (DOXORUBICIN ENCAPSULATED IN LIPOSOMES)", Cancer research, 53(12), 1993, pp. 2796-2802
94. JAKACKI RI; LARSEN RL; BARBER G; HEYMAN S; FRIDMAN M; SILBER JH
    COMPARISON OF CARDIAC-FUNCTION TESTS AFTER ANTHRACYCLINE THERAPY IN CHILDHOOD - IMPLICATIONS FOR SCREENING
    Cancer
    
    R.I. Jakacki et al., "COMPARISON OF CARDIAC-FUNCTION TESTS AFTER ANTHRACYCLINE THERAPY IN CHILDHOOD - IMPLICATIONS FOR SCREENING", Cancer, 72(9), 1993, pp. 2739-2745
95. RHODEN W; HASLETON P; BROOKS N
    ANTHRACYCLINES AND THE HEART
    British Heart Journal
    
    W. Rhoden et al., "ANTHRACYCLINES AND THE HEART", British Heart Journal, 70(6), 1993, pp. 499-502
96. ICHO T; KOJIMA S; SHINOHARA N; KAJIWARA Y; KITABATAKE K; KUBOTA K
    PROTECTIVE EFFECTS OF TETRAHYDRONEOPTERIN AGAINST FREE RADICAL-INDUCED INJURY
    Biochemical pharmacology
    
    T. Icho et al., "PROTECTIVE EFFECTS OF TETRAHYDRONEOPTERIN AGAINST FREE RADICAL-INDUCED INJURY", Biochemical pharmacology, 45(10), 1993, pp. 1953-1958
97. GAUDIN PB; HRUBAN RH; BESCHORNER WE; KASPER EK; OLSON JL; BAUGHMAN KL; HUTCHINS GM
    MYOCARDITIS ASSOCIATED WITH DOXORUBICIN CARDIOTOXICITY
    American journal of clinical pathology
    
    P.B. Gaudin et al., "MYOCARDITIS ASSOCIATED WITH DOXORUBICIN CARDIOTOXICITY", American journal of clinical pathology, 100(2), 1993, pp. 158-163
98. SOBOL MM; AMIET RG; GREEN MD
    INVITRO EVIDENCE FOR DIRECT COMPLEXATION OF ADR-529 187[(+)-1,2-BIS-(3,5-DIOXO-PIPERAZIN-1-YL)PROPANE] ONTO AN EXISTING FERRIC-ANTHRACYCLINE COMPLEX/
    Molecular pharmacology
    
    M.M. Sobol et al., "INVITRO EVIDENCE FOR DIRECT COMPLEXATION OF ADR-529 187[(+)-1,2-BIS-(3,5-DIOXO-PIPERAZIN-1-YL)PROPANE] ONTO AN EXISTING FERRIC-ANTHRACYCLINE COMPLEX/", Molecular pharmacology, 41(1), 1992, pp. 8-16